These videos have been created and funded by Biogen and are intended for healthcare professionals only. They were hosted by AD/PD™ and were previously recorded, so the Q&A functionality is not available. The speakers have been compensated by Biogen for their participation.
Amyloid and Tau in Alzheimer’s disease: Insights into Disease Progression
In this video, Nicolas Mattsson-Carlgren explores the evolving understanding of Alzheimer’s disease (AD) as an amyloid-driven tauopathy including:
- The relationship between amyloid beta and tau
- The correlation between pathology and clinical symptoms
- Biomarker progression across the AD continuum
Moderator:
Holly M. Brothers1
Speaker:
Nicolas Mattson-Carlgren²
1. Biogen, Cambridge, Massachusetts, USA
2. Lund University, Sweden
If you enjoyed this content and would like to see more AD/PD™ content, please visit the AD/PD™ education portal at unlok-education.com/ad-pd/.
Tau and Neurodegeneration: Bridging Pathology and Clinical Progression Through Biomarkers
In this video, Michelle Mielke and Henrik Zetterberg delve into the role of tau and neurodegeneration biomarkers in tracking AD progression including:
- The physiological and pathological forms and functions of tau underpinning the tau cascade
- Tau and neurodegeneration biomarkers to describe and predict AD progression
- How the AD biomarker landscape may evolve over time
Moderator:
Yuval Zabar¹
Speakers:
Michelle Mielke2
Henrik Zetterberg3,4
1. Biogen, Cambridge, Massachusetts, USA
2. Wake Forest University School of Medicine,Winston-Salem, North Carolina, USA
3. University of Gothenburg, Sweden
4. University College London, UK
If you enjoyed this content and would like to see more AD/PD™ content, please visit the AD/PD™ education portal at unlok-education.com/ad-pd/.
Biogen-282525
Date of preparation: April 2026
